RNASET2 and neoplasm: Strikingly, when these mice were pre-treated with the in vivo macrophage-depleting agent clodronate, the tumorigenic potential of HEY3MET2 cells was largely rescued even in the presence of high RNASET2 levels, strongly suggesting an active role for host macrophages in RNASET2-mediated tumor suppression [118].